Search research articles
Contact Us
Filters
Showing results (61-70 of 96) with videos related to
Page
of 10
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
February 4, 2016
Phase II study of fosaprepitant + 5HT3 receptor antagonist + dexamethasone in patients with germ cell tumors undergoing 5-day cisplatin-based chemotherapy: a Hoosier Cancer Research Network study
Nabil Adra, Costantine Albany, Mary J Brames, et al.
The Oncologist
|
April 11, 2025
A phase II trial of sitravatinib + nivolumab after progression on immune checkpoint inhibitor in patients with metastatic clear cell RCC
Andrew W Hahn, Nabil Adra, Ulka Vaishampayan, et al.
Epigenetics
|
October 31, 2020
Hypermethylation and global remodelling of DNA methylation is associated with acquired cisplatin resistance in testicular germ cell tumours
Zeeshan Fazal, Ratnakar Singh, Fang Fang, et al.
Urologic Oncology
|
August 5, 2023
Postchemotherapy retroperitoneal lymph node dissection (PC-RPLND) for seminoma: Limitations of surgical intervention after first-line chemotherapy
Isamu Tachibana, Andre Alabd, Rumeal D Whaley, et al.
Cancer Medicine
|
November 2, 2020
A phase 1 study of combined guadecitabine and cisplatin in platinum refractory germ cell cancer
Costantine Albany, Zeeshan Fazal, Ratnakar Singh, et al.
Clinical Genitourinary Cancer
|
January 10, 2025
Activity of Platinum Chemotherapy in Men With Prostate Cancer With and Without DNA Damage Repair Mutations
Stephanie Lakritz, Andrew Nicklawsky, Vida Alami, et al.
Investigational New Drugs
|
May 25, 2021
Phase II trial of brentuximab vedotin in relapsed/refractory germ cell tumors
Ryan Ashkar, Darren R Feldman, Nabil Adra, et al.
European Urology
|
November 7, 2020
Integrated Expression of Circulating miR375 and miR371 to Identify Teratoma and Active Germ Cell Malignancy Components in Malignant Germ Cell Tumors
Lucia Nappi, Marisa Thi, Nabil Adra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 13, 2023
Surgery in Early Metastatic Seminoma: A Phase II Trial of Retroperitoneal Lymph Node Dissection for Testicular Seminoma With Limited Retroperitoneal Lymphadenopathy
Siamak Daneshmand, Clint Cary, Timothy Masterson, et al.
European Urology
|
January 7, 2024
Safety Analyses of the Phase 3 VISION Trial of [<sup>177</sup>Lu]Lu-PSMA-617 in Patients with Metastatic Castration-resistant Prostate Cancer
Kim N Chi, Andrew J Armstrong, Bernd J Krause, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 96) with videos related to
Sort By:
Page
of 10
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
February 4, 2016
Phase II study of fosaprepitant + 5HT3 receptor antagonist + dexamethasone in patients with germ cell tumors undergoing 5-day cisplatin-based chemotherapy: a Hoosier Cancer Research Network study
Nabil Adra, Costantine Albany, Mary J Brames, et al.
The Oncologist
|
April 11, 2025
A phase II trial of sitravatinib + nivolumab after progression on immune checkpoint inhibitor in patients with metastatic clear cell RCC
Andrew W Hahn, Nabil Adra, Ulka Vaishampayan, et al.
Epigenetics
|
October 31, 2020
Hypermethylation and global remodelling of DNA methylation is associated with acquired cisplatin resistance in testicular germ cell tumours
Zeeshan Fazal, Ratnakar Singh, Fang Fang, et al.
Urologic Oncology
|
August 5, 2023
Postchemotherapy retroperitoneal lymph node dissection (PC-RPLND) for seminoma: Limitations of surgical intervention after first-line chemotherapy
Isamu Tachibana, Andre Alabd, Rumeal D Whaley, et al.
Cancer Medicine
|
November 2, 2020
A phase 1 study of combined guadecitabine and cisplatin in platinum refractory germ cell cancer
Costantine Albany, Zeeshan Fazal, Ratnakar Singh, et al.
Clinical Genitourinary Cancer
|
January 10, 2025
Activity of Platinum Chemotherapy in Men With Prostate Cancer With and Without DNA Damage Repair Mutations
Stephanie Lakritz, Andrew Nicklawsky, Vida Alami, et al.
Investigational New Drugs
|
May 25, 2021
Phase II trial of brentuximab vedotin in relapsed/refractory germ cell tumors
Ryan Ashkar, Darren R Feldman, Nabil Adra, et al.
European Urology
|
November 7, 2020
Integrated Expression of Circulating miR375 and miR371 to Identify Teratoma and Active Germ Cell Malignancy Components in Malignant Germ Cell Tumors
Lucia Nappi, Marisa Thi, Nabil Adra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 13, 2023
Surgery in Early Metastatic Seminoma: A Phase II Trial of Retroperitoneal Lymph Node Dissection for Testicular Seminoma With Limited Retroperitoneal Lymphadenopathy
Siamak Daneshmand, Clint Cary, Timothy Masterson, et al.
European Urology
|
January 7, 2024
Safety Analyses of the Phase 3 VISION Trial of [<sup>177</sup>Lu]Lu-PSMA-617 in Patients with Metastatic Castration-resistant Prostate Cancer
Kim N Chi, Andrew J Armstrong, Bernd J Krause, et al.
Page
of 10